
New Horizon Medical has operated as a dedicated obesity and weight management clinic in Foxborough, Massachusetts since 2011, focusing exclusively on evidence-based interventions for patients struggling with excess weight and metabolic health challenges. The clinic's thirteen-year track record reflects a sustained commitment to addressing obesity as a complex medical condition requiring comprehensive treatment beyond simple calorie restriction. Located in Foxborough, the practice serves patients throughout Norfolk County and the greater Boston metropolitan area who seek medical supervision for weight loss rather than commercial diet programs.
The clinic's treatment protocols center on GLP-1 receptor agonist peptide therapy, specifically Liraglutide and Semaglutide, which work by mimicking incretin hormones that regulate appetite and glucose metabolism. Liraglutide, administered as a daily subcutaneous injection, has demonstrated efficacy in reducing body weight by affecting satiety centers in the brain and slowing gastric emptying. Semaglutide, available in weekly injection form, operates through similar mechanisms with extended duration of action. New Horizon Medical integrates these peptide therapies within structured programs that include baseline metabolic assessment, dosage titration protocols, and ongoing monitoring for both efficacy and potential side effects. The clinic's approach recognizes that peptide therapy produces optimal results when combined with behavioral modification rather than functioning as standalone treatment.
Patients at New Horizon Medical work directly with nurse practitioners who manage peptide prescribing, dosage adjustments, and medical oversight throughout treatment. The clinical team includes nutritionists who develop individualized meal planning strategies based on each patient's metabolic profile, food preferences, and lifestyle constraints. Rather than prescribing restrictive diets, the nutritionists at this Foxborough clinic focus on sustainable eating patterns that patients can maintain long-term. Fitness coaching complements the medical and nutritional components, with coaches helping patients establish realistic activity goals and progressive exercise protocols appropriate for their current fitness level and any mobility limitations related to excess weight.
The in-person consultation model at New Horizon Medical allows for hands-on assessment including body composition analysis, vital sign monitoring, and face-to-face discussion of treatment expectations and potential obstacles. Initial appointments typically involve comprehensive health history review, discussion of previous weight loss attempts, evaluation of obesity-related comorbidities such as type 2 diabetes or hypertension, and collaborative goal-setting between patient and provider. Follow-up visits occur at regular intervals to assess progress, adjust peptide dosages, troubleshoot challenges, and reinforce behavioral strategies. The clinic's program structure emphasizes accountability through scheduled appointments and measurable benchmarks rather than self-directed approaches.
New Horizon Medical's patient population includes individuals who have attempted multiple weight loss methods without sustained success, those with BMI classifications indicating medical intervention, and patients whose physicians have recommended supervised weight management for conditions exacerbated by obesity. The clinic's location in Foxborough provides accessible care for residents of surrounding Massachusetts communities including Mansfield, Sharon, Walpole, and Norwood. With a Google rating of 3.9 stars based on 22 reviews, patient feedback reflects varied experiences with program structure, provider communication, and individual results, which is typical for weight management practices where outcomes depend significantly on patient adherence and biological variability in treatment response.
Topics Mentioned in Reviews
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.